FierceBiotech Radio on Addyi's approval, Allergan's M&A future, and a biotech lawsuit

Aug 20, 2015 11:15am

FiercePharma's Carly Helfand and FierceBiotech's Damian Garde discuss the controversial FDA approval of the first libido drug for women, what Allergan should buy next, and Retrophin's lawsuit against former CEO Martin Shkreli.